Currently, there is no role for Ki-67 staining in ccRCC guideline-based clinical practice, though a handful of studies have associated high Ki-67 staining with more advanced disease stage, worse OS, and worse cancer-specific survival (CSS) [14,15,16,17]. This evidence concerns the gene MKI67 and cancer.